Xylometazoline, 0.1% eucalyptus spray, 10 ml

Xylometazoline is an alpha-adrenergic stimulator, it narrows the blood vessels of the nasal cavity mucosa, eliminating edema and hyperemia of the mucosa.

Easily eases nasal breathing in rhinitis.

The effect occurs within a few minutes and lasts for several hours.

Indications

Acute respiratory diseases with symptoms of rhinitis (runny nose);
acute allergic rhinitis, sinusitis, hay fever;
otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
preparing the patient for diagnostic procedures (rhinoscopy).

Pharmacological effect

Xylometazoline is an alpha-adrenergic stimulant that constricts the blood vessels of the nasal mucosa, eliminating swelling and hyperemia of the mucous membrane.

Facilitates nasal breathing during rhinitis.

The action begins within a few minutes and lasts for several hours.

Special instructions

Before use, it is necessary to clean the nasal passages.

Should not be used for more than 7 days.

Typically, xylometazoline does not affect performance and does not make it difficult for vehicle drivers to work or control moving machinery.

In some cases, frequent and/or long-term use of the drug may lead to adverse reactions that impair the ability to drive a car or operate machinery.

Active ingredient

Xylometazoline

Composition

1 ml of solution contains:

Active ingredient:

xylometazoline hydrochloride – 1.0 mg;

Excipients:

benzalkonium chloride – 0.15 mg,

disodium edetate dihydrate – 0.5 mg,

potassium dihydrogen phosphate – 3.63 mg,

sodium hydrogen phosphate dodecahydrate – 7.13 mg,

sodium chloride – 7.0 mg,

eucalyptus leaf oil – 0.5 mg,

sorbitol – 8.0 mg,

glycerol – 4.0 mg,

macrogol glyceryl hydroxystearate – 3.4 mg,

purified water – up to 1 ml.

Pregnancy

With caution

Contraindications

Hypersensitivity to the components of the drug,
arterial hypertension,
tachycardia,
pronounced atherosclerosis,
glaucoma,
atrophic rhinitis,
thyrotoxicosis,
surgical interventions on the meninges (in history),
children under 6 years of age.
Do not use during therapy with monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants.

With caution: coronary heart disease (angina pectoris III-IV functional class), prostatic hyperplasia, diabetes mellitus, pregnancy, lactation.

Side Effects

With frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion; swelling of the nasal mucosa, palpitations, tachycardia, arrhythmia, increased blood pressure, vomiting, headache, insomnia, blurred vision; depression (with long-term use of high doses).

Interaction

Incompatible with MAO inhibitors and tricyclic antidepressants.

Overdose

No data available.

Storage conditions

At temperatures from 0 to 25 ° C in a dry place, protected from light.

Shelf life

3 years.

Manufacturer

Vips-Med Firm, Russia